Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Grill

Showing results (71-80 of 266) with videos related to

Pageof 27
Sort By:
Pediatric Blood & Cancer|January 17, 2009
Relapses of optic pathway tumors after first-line chemotherapyValérie de Haas, Jacques Grill, Marie-Anne Raquin, et al.
Plos One|April 10, 2012
Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcomeJean-Francois Brasme, Jacques Grill, Francois Doz, et al.
Research in Developmental Disabilities|October 16, 2012
Time perception in children treated for a cerebellar medulloblastomaSylvie Droit-Volet, Pierre S Zélanti, Georges Dellatolas, et al.
Frontiers in Medicine|March 13, 2023
Multimodal MRI radiomic models to predict genomic mutations in diffuse intrinsic pontine glioma with missing imaging modalitiesFahad Khalid, Jessica Goya-Outi, Thibault Escobar, et al.
Pediatric Blood & Cancer|June 1, 2005
Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumorsVirginie Kieffer-Renaux, Delphine Viguier, Marie-Anne Raquin, et al.
Journal of Neuro-Oncology|August 23, 2011
Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine gliomaAndrea Chassot, Sandra Canale, Pascale Varlet, et al.
Acta Neuropathologica Communications|June 26, 2024
Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-alteredArnault Tauziède-Espariat, David Castel, Yassine Ajlil, et al.
Pediatric Blood & Cancer|May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
Cancer|February 6, 2009
Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumorsStephanie Puget, Nathalie Boddaert, Delphine Viguier, et al.
Journal of Neurosurgery|November 8, 2005
Preoperative chemotherapy in children with high-risk medulloblastomas: a feasibility studyJacques Grill, Arielle Lellouch-Tubiana, Selma Elouahdani, et al.
Pageof 27

Showing results (71-80 of 266) with videos related to

Sort By:
Pageof 27
Pediatric Blood & Cancer|January 17, 2009
Relapses of optic pathway tumors after first-line chemotherapyValérie de Haas, Jacques Grill, Marie-Anne Raquin, et al.
Plos One|April 10, 2012
Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcomeJean-Francois Brasme, Jacques Grill, Francois Doz, et al.
Research in Developmental Disabilities|October 16, 2012
Time perception in children treated for a cerebellar medulloblastomaSylvie Droit-Volet, Pierre S Zélanti, Georges Dellatolas, et al.
Frontiers in Medicine|March 13, 2023
Multimodal MRI radiomic models to predict genomic mutations in diffuse intrinsic pontine glioma with missing imaging modalitiesFahad Khalid, Jessica Goya-Outi, Thibault Escobar, et al.
Pediatric Blood & Cancer|June 1, 2005
Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumorsVirginie Kieffer-Renaux, Delphine Viguier, Marie-Anne Raquin, et al.
Journal of Neuro-Oncology|August 23, 2011
Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine gliomaAndrea Chassot, Sandra Canale, Pascale Varlet, et al.
Acta Neuropathologica Communications|June 26, 2024
Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-alteredArnault Tauziède-Espariat, David Castel, Yassine Ajlil, et al.
Pediatric Blood & Cancer|May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
Cancer|February 6, 2009
Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumorsStephanie Puget, Nathalie Boddaert, Delphine Viguier, et al.
Journal of Neurosurgery|November 8, 2005
Preoperative chemotherapy in children with high-risk medulloblastomas: a feasibility studyJacques Grill, Arielle Lellouch-Tubiana, Selma Elouahdani, et al.
Pageof 27